Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

Dr. Katherine Saunders, at Weill Cornell Medicine, joined ABC News' to discuss a new daily weight loss pill by Eli Lilly saying it "opens up opportunities" to treat diseases. Dr. Rekha Kumar ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...

Prediabetes is a clinical inflection point and a modifiable risk state. Small shifts in care can translate to big shifts in ...